drugset / Trial / NCT05545137
Clinical Trial of Pivmecillinam Hydrochloride Tablets in the Treatment of Uncomplicated Urinary Tract Infection
RandomizedParallel-groupDouble-blindTreatment
Summary
the purpose of this study is to evaluate the efficacy and safety of pivmecillinam hydrochloride tablets in the treatment of uncomplicated urinary tract infection in China
Timeline
- Start
- 2022-09-29
- Primary completion
- 2024-02-05
- Completion
- 2024-02-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fosfomycin | Small molecule | 3 g | Oral |
| Subject | Pivmecillinam | Small molecule | 400 mg | Oral |